부산대학교 도서관

Patients diagnosed with myasthenia gravis, may suffer from life-threatening condition due to general weakness or respiratory muscle weakness. The medication options for patients with myasthenia gravis vary from treatment methods, time to symptom relief, and to prices. In addition to the clinical evaluation of the physician, most of the treatment options depend on the preference of patient and patient's family. The purpose of this research is to establish Patient Decision Aids (PDAs) that meet the empirical evidence and patient preferences to increase the patient's knowledge of the decision and to help patients and medical staff with Shared-Decision Making (SDM). A collaborative team was formed to discuss the working process, and developed first version PDA into final version after alpha and beta tests. The study provided treatment options for patients with myasthenia gravis, and the PDA based on evidence will be applied to patients in the future and continue update according to relevant data.